Literature DB >> 1685857

Mechanism of HIV-1 entry into CD4+ T cells.

B S Stein1, E G Engleman.   

Abstract

Although the mechanism responsible for HIV-1 entry into susceptible CD4+ T cells is incompletely understood, a number of key components are now known. For example, the tropism of HIV-1 for cells expressing the CD4 membrane glycoprotein reflects the use of this protein as a specific viral receptor to which the HIV-1 gp120 envelope protein binds with high affinity. This binding apparently results in the exposure of hydrophobic domains of the gp41 transmembrane protein to apposing plasma membrane components, resulting in the fusion of viral and plasma membranes to one another which, in turn, releases HIV-1 RNA into the cytosol. This fusion event, which is requisite for viral entry as well as HIV-1 associated syncytia formation, occurs in a pH-independent fashion, but requires antecedent T cell activation. In the absence of T cell stimuli, resting CD4+ cells are resistant to HIV-1 entry, which may explain the observation that at any given time the vast majority of CD4+ T cells in HIV-1 seropositive patients are not infected despite the presence of relatively large quantities of free virus in the blood of such patients. The mechanism of HIV-1 entry into other CD4+ cell types, such as macrophages and dendritic cells, remains to be determined.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1685857     DOI: 10.1007/978-1-4684-5976-0_6

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  5 in total

1.  Viral infection: Moving through complex and dynamic cell-membrane structures.

Authors:  Jonathan Barroso-González; Laura García-Expósito; Julià Blanco; Agustín Valenzuela-Fernández; Isabel Puigdomènech; Laura de Armas-Rillo; José-David Machado
Journal:  Commun Integr Biol       Date:  2011-07-01

2.  The molecular target of bicyclams, potent inhibitors of human immunodeficiency virus replication.

Authors:  K de Vreese; V Kofler-Mongold; C Leutgeb; V Weber; K Vermeire; S Schacht; J Anné; E de Clercq; R Datema; G Werner
Journal:  J Virol       Date:  1996-02       Impact factor: 5.103

Review 3.  Role of Langerhans cells and other dendritic cells in viral diseases.

Authors:  E Sprecher; Y Becker
Journal:  Arch Virol       Date:  1993       Impact factor: 2.574

4.  Phase I/II vaccination study of recombinant peptide F46 corresponding to the HIV-1 transmembrane protein coupled with 2.4 dinitrophenyl (DNP) Ficoll.

Authors:  S Schwander; M Opravil; R Lüthy; D G Hanson; J Schindler; A Dawson; B Letwin; M Dietrich
Journal:  Infection       Date:  1994 Mar-Apr       Impact factor: 3.553

5.  Diminished reovirus capsid stability alters disease pathogenesis and littermate transmission.

Authors:  Joshua D Doyle; Jennifer E Stencel-Baerenwald; Courtney A Copeland; Jillian P Rhoads; Judy J Brown; Kelli L Boyd; James B Atkinson; Terence S Dermody
Journal:  PLoS Pathog       Date:  2015-03-04       Impact factor: 6.823

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.